advanced stages of Multiple Sclerosis (MS). Their frequency increases from clinically isolated syndromes, to relapsing-remitting and secondary progressive MS. The most frequently impaired functions are information…
inflammatory, demyelinating disease of the central nervous system. Most patients have a relapsing-remitting disease type, for which medicines are mostly dedicated. Clinical course of some patients will transition
Statement of the Problem: Multiple sclerosis (M.S) is a chronic, immune-mediated, relapsing-remitting disorder affecting young adults, which its pathogenesis is still largely unknown. Multiple sclerosis is the commonest
characterized by chronic inflammation, demyelination, gliosis and neuronal loss. The disease course can be relapsing-remitting or progressive type. Symptoms of Multiple Sclerosis are extremely varied and depend on…
suppress MS. Benign multiple sclerosis (BMS) occurs in about 15% of patients with relapsing-remitting MS (RRMS) that over time do not develop significant neurological disability. Aim of this study
With regards to the type of MS, most patients in our study have a relapsing-remitting type (75% of them). The mean score of sleep quality in all 7 domains
male/female ratio was 7/42. Also, 66.7% of the patients were suffering from relapsing-remitting (RR) type disease, and most lesions on MRI in these patients were observed
Oral feeding of GTB suppressed clinical symptoms of adoptively-transferred relapsing-remitting (RR) EAE in recipient mice and suppressed the generation of encephalitogenic T cells in donor mice. GTB also
Inflammatory bowel diseases (IBD) are chronic inflammatory pathologies of the gut, characterized by a relapsing-remitting course. Although IBD pathogenesis is not fully understood, epidemiological and experimental data…
that cerebellar abnormalities in fractional anisotropy (FA) may be involved in cognitive dysfunctions in Relapsing-Remitting (RR)-Multiple Sclerosis (MS). Objective: The aim of our study was to investigate
with MS (15 with primary progressive, 40 with secondary progressive and 76 people with relapsing-remitting MS). The mean age was 48 years (SD 9.8), mean MS duration
symptoms including neurological symptoms with visual, motor and sensory problems. MS is classified into: Relapsing-remitting MS which later on leads to secondary progressive and primary progressive MS and lastly
multiple sclerosis, the experimental autoimmune encephalomyelitis (EAE) induction, using MOG35-55 immunization with a relapsing-remitting course. AMSCs were previously treated with LPA1-modulators and analyzed in vivo…
examinations at study entry. Methods and findings: A total of 45 patients with relapsing-remitting MS [males, 12; females 33; at entry: mean age, 41 ± 10 years; mean disease duration
study were to evaluate expression level of FasL in whole blood from patients with Relapsing-Remitting (RR) form of MS, and to survey the association of FasL expression with risk
pharmacotherapy. Herein, we present a case of a 39-year-old female patient with relapsing-remitting multiple sclerosis (MS), who was receiving immunomodulatory therapy and subsequently developed severe
Hizentra®) during the next pregnancy after abortion. Interferon beta-1a for the treatment of relapsing-remitting multiple sclerosis was stopped before pregnancy. During pregnancy only subcutaneous immunoglobulin was…
patient suffered acute myelitis. Our patient represents a rare case of late onset Relapsing-Remitting Multiple Sclerosis (RRMS) presenting with an eight-and-a-half-syndrome. Apart from the clinical
cognitive impairment in MS patients. Material and Method: 19 subjects with a diagnosis of relapsing-remitting MS (RRMS) based on the revised McDonald criteria and 20 age-matched healthy controls
myelin basic protein (MBP), and approved as an immunoregulatory drug for the treatment of relapsing-remitting MS. The mechanism of action of GA in MS patients and the animal model
study, the results of high dose intravenous monthly pulse CYC on patients with worsening relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) were evaluated. Methods: Fifty
least one type of pain or unpleasant pain sensation. Pain was more frequent in relapsing-remitting form of MS than in secondary progressive MS (p<0.0001) and less frequent